An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical Practice
NCT01498900
·
clinicaltrials.gov ↗
COMPLETED
Status
30554
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
repaglinide
Sponsor
Novo Nordisk A/S